A pH-sensitive, neurogenic pathway mediates disease severity in a model of post-ERCP pancreatitis

Gut

Volumn 57, Issue 11, 2008, Pages 1566-1571

  Noble, M D ^a   Romac, J ^a   Vigna, S R ^a   Liddle, R A ^a,b  

^a DUKE UNIVERSITY   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MEGLUMINE DIATRIZOATE; RESINIFERATOXIN; VANILLOID RECEPTOR 1;

ACIDITY; ALKALINITY; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG INDUCED DISEASE; EDEMA; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; HISTOPATHOLOGY; MALE; NERVE FIBER A DELTA; NERVE FIBER C; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PANCREATITIS; PRIORITY JOURNAL; RAT; SENSORY NERVE; SENSORY NERVE CELL;

ANIMALS; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CONTRAST MEDIA; DITERPENES; HYDROGEN-ION CONCENTRATION; MALE; NEUROGENIC INFLAMMATION; NEURONS, AFFERENT; PANCREAS; PANCREATITIS; RATS; RATS, SPRAGUE-DAWLEY; SEVERITY OF ILLNESS INDEX; TRPV CATION CHANNELS;

EID: 54349119629     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2008.148551     Document Type: Article

References (39)

1. Freeman ML. Post-ERCP pancreatitis: patient and technique-related risk factors. J Pancreas 2002;3:169-76.
2. Freeman ML, Guda NM. Prevention of post-ERCP pancreatitis: a comprehensive review. Gastrointest Endosc 2004;59:845-64.
3. Hannigan BF, Keeling PW, Slavin B, et al. Hyperamylasemia after ERCP with ionic and non-ionic contrast media. Gastrointest Endosc 1985;31:109-10.
4. Johnson GK, Geenen JE, Bedford RA, et al. A comparison of nonionic versus ionic contrast media: results of a prospective, multicenter study. Midwest Pancreaticobiliary Study Group. Gastrointest Endosc 1995;42:312-6.
5. Sherman S, Hawes RH, Rathgaber SW, et al. Post-ERCP pancreatitis: randomized, prospective study comparing a low- and high-osmolality contrast agent. Gastrointest Endosc 1994;40:422-7.
6. Cunliffe WJ, Cobden I, Lavelle MI, et al. A randomised, prospective study comparing two contrast media in ERCP. Endoscopy 1987;19:201-2.
7. Manolakopoulos S, Avgerinos A, Vlachogiannakos J, et al. Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial. Gastrointest Endosc 2002;55:470-5.
8. Budzynska A, Marek T, Nowak A, et al. A prospective, randomized, placebo-controlled trial of prednisone and allopurinol in the prevention of ERCP-induced pancreatitis. Endoscopy 2001;33:766-72.
9. Cavallini G, Tittobello A, Frulloni L, et al. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy - Italian Group. N Engl J Med 1996;335:919-23.
10. Dumot JA, Conwell DL, Zuccaro G Jr, et al. A randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis. Am J Gastroenterol 2001;96:2098-102.
11. Murray B, Carter R, Imrie C, et al. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology 2003;124:1786-91.
12. Toulon P, Chadeuf G, Bouillot JL, et al. Involvement of heparin cofactor II in chymotrypsin neutralization and in the pancreatic proteinase-antiproteinase interaction during acute pancreatitis in man. Eur J Clin Invest 1991;21:303-9.
13. Bhatia M, Saluja AK, Hofbauer B, et al. Role of substance P and the neurokinin 1 receptor in acute pancreatitis and pancreatitis-associated lung injury. Proc Natl Acad Sci U S A 1998;95:4760-5.
14. Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neuroscience 1988;24:739-68.
15. Kenins P. Identification of the unmyelinated sensory nerves which evoke plasma extravasation in response to antidromic stimulation. Neurosci Lett 1981;25:137-41.
16. Baluk P, Bertrand C, Geppetti P, et al. NK1 receptors mediate leukocyte adhesion in neurogenic inflammation in the rat trachea. Am J Physiol 1995;268(2 Pt 1):L263-9.
17. Saban MR, Saban R, Bjorling D, et al. Involvement of leukotrienes, TNF-alpha, and the LFA-1/ICAM-1 interaction in substance P-induced granulocyte infiltration. J Leukoc Biol 1997;61:445-51.
18. Tanabe T, Otani H, Bao L, et al. Intracellular signaling pathway of substance P-induced superoxide production in human neutrophils. Eur J Pharmacol 1996;299:187-95.
19. Caterina MJ, Schumacher MA, Tominaga M, et al. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 1997;389:816-24.
20. Caterina MJ, Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci 2001;24:487-517.
21. Nathan JD, Patel AA, McVey DC, et al. Capsaicin vanilloid receptor-1 mediates substance P release in experimental pancreatitis. Am J Physiol Gastrointest Liver Physiol 2001;281:G1322-8.
22. Nathan JD, Peng RY, Wang Y, et al. Primary sensory neurons: a common final pathway for inflammation in experimental pancreatitis in rats. Am J Physiol Gastrointest Liver Physiol 2002;283:G938-46.
23. Noble MD, Romac J, Wang Y, et al. Local disruption of the celiac ganglion inhibits substance P release and ameliorates caerulein-induced pancreatitis in rats. Am J Physiol Gastrointest Liver Physiol 2006;291:G128-34.
24. Maa J, Grady EF, Yoshimi SK, et al. Genetic deletion of the neurokinin-1 receptor improves survival in diet-induced hemorrhagic pancreatitis in mice. Surg Forum 1999;50:34-5.
25. He ZJ, Winston JH, Yusuf TE, et al. Intraductal administration of an NK1 receptor antagonist attenuates the inflammatory response to retrograde infusion of radiological contrast in rats: implications for the pathogenesis and prevention of ERCP-induced pancreatitis. Pancreas 2003;27:e13-7.
26. Dray A. Neuropharmacological mechanisms of capsaicin and related substances. Biochem Pharmacol 1992;44:611-5.
27. Szallasi A. Vanilloid (capsaicin) receptors in health and disease. Am J Clin Pathol 2002;118:110-21.
28. Kivisaari L. Contrast absorption and pancreatic inflammation following experimental ERCP. Invest Radiol 1979;14:493-7.
29. Jung DH. Preparation and application of procion yellow starch for amylase assay. Clin Chim Acta 1980;100:7-11.
30. Bradley PP, Priebat DA, Christensen RD, et al. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206-9.
31. Spormann H, Sokolowski A, Letko G. Effect of temporary ischemia upon development and histological patterns of acute pancreatitis in the rat. Path Res Pract 1989;184:507-513.
32. Nathan JD, Romac J, Peng RY, et al. Transgenic expression of pancreatic secretory trypsin inhibitor-I ameliorates secretagogue-induced pancreatitis in mice. Gastroenterology 2005;128:717-27.
33. Szallasi A, Blumberg PM. Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper. Neuroscience 1989;30:515-20.
34. Holzer P. Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol Rev 1991;43:143- 201.
35. Figini M, Emanueli C, Grady EF, et al. Substance P and bradykinin stimulate plasma extravasation in the mouse gastrointestinal tract and pancreas. Am J Physiol 1997;272(4 Pt 1):G785-93.
36. Bowden JJ, Garland AM, Baluk P, et al. Direct observation of substance P-induced internalization of neurokinin 1 (NK1) receptors at sites of inflammation. Proc Natl Acad Sci U S A 1994;91:8964-8.
37. Renzi D, Pellegrini B, Tonelli F, et al. Substance P (neurokinin-1) and neurokinin A (neurokinin-2) receptor gene and protein expression in the healthy and inflamed human intestine. Am J Pathol 2000;157:1511-22.
38. Ralevic V, Jerman JC, Brough SJ, et al. Pharmacology of vanilloids at recombinant and endogenous rat vanilloid receptors. Biochem Pharmacol 2003;65:143-51.
39. Olah Z, Szabo T, Karai L, et al. Ligand-induced dynamic membrane changes and cell deletion conferred by vanilloid receptor 1. J Biol Chem 2001;276:11021-30.